Fidelity Investments
DRTS icon

Fidelity Investments’s Alpha Tau Medical DRTS Stock Holding History

Fidelity Investments’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-362,046
Closed -$1.04M – 5422
2023
Q1 		$1.04M Hold
362,046
– – ﹤0.01% 2517
2022
Q4 		$1.15M Buy
362,046
+20,167
+6% +$83.5K ﹤0.01% 2504
2022
Q3 		$2M Buy
341,879
+33,301
+11% +$294K ﹤0.01% 2424
2022
Q2 		$2.78M Hold
308,578
– – ﹤0.01% 2401
2022
Q1 		$3.64M Buy
+308,578
New +$3.63M ﹤0.01% 2443

Other funds holding DRTS

Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.39B AUM 18.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Grey Street Capital Chicago, Illinois $738M AUM 50.4% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.31B AUM 28.11% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.01B AUM 19.32% 1-Year Est. Return